Department of Surgery, I.P. Pavlov Federal Medical University, 197022 St. Petersburg, Russia.
World J Gastroenterol. 2013 Jan 14;19(2):209-18. doi: 10.3748/wjg.v19.i2.209.
To investigate the effect of local intestinal perfusion with hypertonic saline (HTS) on intestinal ischemia-reperfusion injury (IRI) in both ex vivo and in vivo rat models.
All experiments were performed on male Wistar rats anesthetized with pentobarbital sodium given intraperitoneally at a dose of 60 mg/kg. Ex vivo vascularly perfused rat intestine was subjected to 60-min ischemia and either 30-min reperfusion with isotonic buffer (controls), or 5 min with HTS of 365 or 415 mOsm/L osmolarity (HTS(365mOsm) or HTS(415mOsm), respectively) followed by 25-min reperfusion with isotonic buffer. The vascular intestinal perfusate flow (IPF) rate was determined by collection of the effluent from the portal vein in a calibrated tube. Spontaneous intestinal contraction rate was monitored throughout. Irreversible intestinal injury or area of necrosis (AN) was evaluated histochemically using 2.3.5-triphenyltetrazolium chloride staining. In vivo, 30-min ischemia was followed by either 30-min blood perfusion or 5-min reperfusion with HTS(365mOsm) through the superior mesenteric artery (SMA) followed by 25-min blood perfusion. Arterial blood pressure (BP) was measured in the common carotid artery using a miniature pressure transducer. Histological injury was evaluated in both preparations using the Chui score.
Ex vivo, intestinal IRI resulted in a reduction in the IPF rate during reperfusion (P < 0.05 vs sham). The postischemic recovery of the IPF rate did not differ between the controls and the HTS(365mOsm) group. In the HTS(415mOsm) group, postischemic IPF rates were lower than in the controls and the HTS(365mOsm) group (P < 0.05). The intestinal contraction rate was similar at baseline in all groups. An increase in this parameter was observed during the first 10 min of reperfusion in the control group as compared to the sham-treated group, but no such increase was seen in the HTS(365mOsm) group. In controls, AN averaged 14.8% ± 5.07% of the total tissue volume. Administration of HTS(365mOsm) for 5 min after 60-min ischemia resulted in decrease in AN (5.1% ± 1.20% vs controls, P < 0.01). However, perfusion of the intestine with the HTS of greater osmolarity (HTS(415mOsm)) failed to protect the intestine from irreversible injury. The Chiu score was lower in the HTS(365mOsm) group in comparison with controls (2.4 ± 0.54 vs 3.2 ± 0.44, P = 0.042), while intestinal perfusion with HTS(415mOsm) failed to improve the Chiu score. Intestinal reperfusion with HTS(365mOsm) in the in vivo series secured rapid recovery of BP after its transient fall, whereas in the controls no recovery was seen. The Chiu score was lower in the HTS(365mOsm) group vs controls (3.1 ± 0.26 and 3.8 ± 0.22, P = 0.0079 respectively,), although the magnitude of the effect was lower than in the ex vivo series.
Brief intestinal postischemic perfusion with HTS(365mOsm) through the SMA followed by blood flow restoration is a protective procedure that could be used for the prevention of intestinal IRI.
研究局部肠道高渗盐水(HTS)灌注对离体和在体大鼠肠缺血再灌注损伤(IRI)的影响。
所有实验均在腹腔内给予戊巴比妥钠 60mg/kg 麻醉的雄性 Wistar 大鼠上进行。离体血管灌注的大鼠肠经历 60 分钟缺血,然后用等渗缓冲液进行 30 分钟再灌注(对照组),或用 365 或 415mOsm/L 渗透压的 HTS(HTS(365mOsm)或 HTS(415mOsm))处理 5 分钟,然后再用等渗缓冲液进行 25 分钟再灌注。通过门静脉收集流出物来确定肠道血管灌注流量(IPF)率。整个过程中监测自发性肠道收缩率。用 2.3.5-氯化三苯基四氮唑染色法评估不可逆性肠道损伤或坏死面积(AN)。在体内,30 分钟缺血后,通过肠系膜上动脉(SMA)进行 5 分钟 HTS(365mOsm)再灌注,然后进行 25 分钟血液灌注。通过微型压力传感器测量颈总动脉中的动脉血压(BP)。使用 Chui 评分评估两种制剂中的组织学损伤。
离体时,肠道 IRI 导致再灌注期间 IPF 率降低(P < 0.05 与假手术组比较)。对照组和 HTS(365mOsm)组之间的缺血后 IPF 恢复率没有差异。在 HTS(415mOsm)组中,缺血后 IPF 率低于对照组和 HTS(365mOsm)组(P < 0.05)。所有组的肠道收缩率在基线时相似。与假手术组相比,对照组在再灌注的前 10 分钟观察到该参数增加,但在 HTS(365mOsm)组中未观察到这种增加。在对照组中,AN 平均占总组织体积的 14.8%±5.07%。60 分钟缺血后给予 5 分钟 HTS(365mOsm)处理可降低 AN(5.1%±1.20%与对照组比较,P < 0.01)。然而,用更高渗透压的 HTS(HTS(415mOsm))灌注肠未能保护肠免受不可逆损伤。与对照组相比,HTS(365mOsm)组的 Chiu 评分较低(2.4±0.54 与 3.2±0.44,P = 0.042),而用 HTS(415mOsm)灌注肠未能改善 Chiu 评分。在体内系列中,用 HTS(365mOsm)进行肠道再灌注可确保其短暂下降后的血压迅速恢复,而在对照组中则未观察到恢复。HTS(365mOsm)组的 Chiu 评分低于对照组(3.1±0.26 和 3.8±0.22,P = 0.0079),尽管作用的幅度低于离体系列。
短暂的肠系膜上动脉 HTS(365mOsm)灌注后恢复血流是一种保护性程序,可用于预防肠道 IRI。